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Abstract 
Introduction: This feasibility study aimed to 1) develop a clinical protocol using a 
LTP-like (long term potentiation) repetitive stimulation protocol for transcutaneous 
electrical nerve stimulation (TENS) in patients with upper limb complex regional pain 
syndrome (CRPS) and 2) develop a research protocol for a single-blind randomised 
controlled trial (RCT) investigating the efficacy of TENS for CRPS. 
Methods: This small-scale single-blind feasibility RCT planned to randomise 30 
patients with upper limb CRPS to either a variant of TENS or placebo TENS for 3 
weeks. Stimulation comprised 20 pulses over 1-second with a non-stimulation interval 
of 5-seconds, a so-called repetitive electrical stimulation protocol following the timing 
of LTP. Pain, function and body image were measured at baseline, post-treatment and 
3-months follow-up. At 3-months, participants were invited to one-to-one interviews, 
which were analysed thematically.   
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Results: A TENS protocol with electrodes applied proximal to the area of allodynia in 
the region of the upper arm was developed. Participant concordance with the protocol 
was high. The sample size was small (TENS (n=6), placebo (n=2)). Mean (SD) pain 
intensity for the TENS group on a 0-10 scale was 7.2 (2.4), 6.6 (2.8), and 7.8 (1.9), at 
baseline, post-treatment and 3-month follow-up respectively. Qualitative data suggested 
some patients found TENS beneficial, easy to use, and were still using at 3-months.  
Discussion: Patients tolerated TENS well and important methodological information to 
facilitate the design of a large-scale trial was obtained. [ISRCTN48768534] 
Key words: Complex regional pain syndrome; TENS; feasibility study; upper limb 
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Introduction 
Transcutaneous electrical nerve stimulation (TENS) is commonly used for pain relief, 
has few side-effects and can be self-administered using relatively inexpensive devices.1 
Recent guidelines2 identify TENS as a potential therapy for patients with Complex 
Regional Pain Syndrome (CRPS). However no randomised controlled trials (RCTs) 
have investigated the effectiveness of TENS for CRPS.  
 
The primary mechanism by which TENS purports to work is via the pain gate. In brief, 
TENS activates large diameter, low threshold mechanosensitive afferents resulting in 
synaptic inhibition of nociceptive transmission in the spinal cord and brainstem.3 We 
propose that TENS may have additional mechanisms of action for painful conditions 
that involve perceptual distortions of the affected area. 
 
Persistent pain can disrupt the representation of the painful body part in the brain of 
CRPS patients, often referred to as cortical reorganisation/disruption. This cortical 
reorganisation is hypothesised to play a role in maintaining the pain.4,5 Sensory 
retraining can be defined as any intervention aimed at restoring the normal body image 
of that area. Evidence from patients with phantom limb pain and CRPS suggest that 
sensory retraining of the painful body part, by physical stimulation of that body part, 
can normalise the disrupted body image and reduce pain.6-8 TENS, delivered in a 
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synchronised pulsed fashion across two or more receptive fields, commonly referred to 
as repetitive electrical stimulation, has been used as a method of sensory retraining in 
individuals with diminished sensorimotor performance, such as older adults and stroke 
patients.9-12 Additionally, a recent non-randomised study using high-frequency 
repetitive sensory (LTP)-like (long term potentiation) stimulation suggested it could 
reduce sensory impairment in patients with CRPS.13 To date no RCTs have investigated 
the effect of TENS on sensorimotor performance in patients with CRPS. However, it 
has been shown that TENS relieves phantom pain and facilitates perceptual embodiment 
of prosthetic limbs14 when TENS sensation is projected into the phantom limb itself.15 
We have hypothesised that TENS may be mimicking normal neural input to restore 
disrupted body image.16  
 
There is a need for a full scale blinded RCT to investigate the efficacy of TENS to 
reduce pain and improve sensorimotor function in patients with CRPS. However, 
beforehand a feasibility study is warranted to ensure the methodological components of 
the protocol are fit for purpose.17 Many full-scale trials fail because a feasibility study 
was not undertaken.18 Thus the purpose of this feasibility study was to 1) develop a 
clinical protocol using a LTP-like repetitive stimulation protocol for TENS in patients 
with CRPS and 2) develop a research protocol for a single-blind RCT investigating the 
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efficacy of TENS for CRPS. To achieve these aims this study had a number of 
objectives (see table 1). 
Insert table 1 
 
Method 
Study overview 
This mixed-methods single-blind placebo controlled feasibility study randomised 
participants with CRPS into an intervention or a placebo group. The aims were to 1) 
develop a clinical protocol using a LTP-like repetitive stimulation protocol for TENS in 
patients with CRPS and 2) develop a research protocol for a single-blind RCT 
investigating the efficacy of TENS for CRPS. 
 
Participants, recruitment, screening and randomisation 
The study aimed to recruit 30 participants from a regional NHS hospital in the north 
east of England. This study was approved by the NRES Committee North East - York 
NHS Ethics Committee (REC approval number: 13/NE/0286). Participants were 
eligible for inclusion if they were ≥18 years of age and had type-1 CRPS of the upper 
limb defined by the Budapest criteria19 for ≥6 months’ duration. Those who once 
fulfilled the criteria, no longer did, but had ongoing pain were classed as CRPS-NOS 
[not otherwise specified], and were also included. Participants were excluded if they 
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found TENS as applied in the 1st session unacceptable/intolerable, lacked the capacity to 
give informed consent, had any neurological condition (e.g. stroke) or were unable to 
speak English. Eligible participants provided informed consent and were randomly 
allocated to TENS or placebo TENS using a random number generator and pre-filled 
concealed envelopes by a team member uninvolved in participant contact. As this was a 
feasibility study an apriori sample size calculation was not undertaken though the 
sample size was in keeping with recommendations that such trials should aim for 
approximately n=12 in each group.20 This study aimed to recruit 30 participants which 
would allow for a 20% drop out rate whilst still achieving n=12 per group.  
 
Preliminary rehearsal of process 
Based upon our previous clinical experience and direct patient involvement in the study 
design, it was felt that CRPS patients were unlikely to tolerate applying TENS 
electrodes to the painful site. Thus, we proposed TENS be applied to the upper arm, 
proximal to the affected site and the TENS sensation projected distally into the affected 
area. We easily achieved this distal projection in unimpaired participants (unpublished). 
This simple adaption of conventional TENS technique (e.g. placing the electrodes over 
the painful area) overcame this unique CRPS barrier. 
 
Intervention 
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TENS, in this study, was delivered using a commercially available two-channel TENS 
unit (Elpha II 3000 muscle and pain stimulator, Danmeter). A detailed demonstration on 
self-application and a simple instruction sheet to facilitate home use was provided. 
Pulsed, synchronised dual channel TENS was self-administered (for 90 minutes) at 
home, daily, over a period of 3 weeks. The stimulation pattern described by Freyer et al. 
(2012)12 was used: 20 pulses delivered over a 1-second period (20Hz stimulation 
frequency) with a non-stimulation interval of 5-seconds. This form of stimulation is 
commonly referred to as repetitive electric stimulation and its primary proposed 
mechanism of action is cortical reorganisation rather than via the classic gate control 
mechanism associated with conventional TENS stimulation. A self-report diary 
monitored home programme concordance. All participants received usual care provided 
by the same physiotherapist to maximise standardisation. Usual care physiotherapy 
included but was not limited to; advice, education, exercise, Cognitive Behavioural 
Therapy, motor imagery, hand laterality recognition training, desensitizing and 
hydrotherapy. It excluded TENS or other electrotherapy modalities. The number of 
usual care physiotherapy sessions was recorded for all participants. 
 
Placebo 
The Placebo group received TENS in an identical manner to the active intervention 
except that no electrical current was delivered, although the power light flashed 
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pulsatingly indicating that the device was switched on. It was impossible to blind 
participants to receiving a strong non-painful TENS sensation. However, we attempted 
to markedly reduce this bias by introducing uncertainty as to whether a strong sensation 
was a pre-requisite for pain relief. Hence, information orientating participants to study 
aims and procedures were designed to raise uncertainty in the mind of the participant 
about whether they received an active intervention or not. This approach has been used 
successfully in previous studies.21 Blinding the therapist was not possible. Similar to the 
participants in the intervention group, all participants in the placebo group received 
usual care provided by the same physiotherapist and the number of usual care 
physiotherapy sessions was recorded for all participants. 
 
Clinical Outcomes 
Pain: Pain was measured using a Visual Analogue Scale (VAS) with the question “How 
would you rate your average pain over the last two days?” and anchor statements of “no 
pain” and “worst imaginable pain”. The VAS is valid and reliable.22 The VAS data was 
collected at baseline; post treatment and 3-month follow-up. A change of ≥30% was 
considered clinically meaningful.23 As pain was considered the primary outcome 
measure, the effect size was also calculated for this outcome and used to calculate the 
sample size for a future fully powered trial. Effect size was calculated as the change 
from pre to post treatment divided by the standard deviation of the baseline values.24 
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 Pain Diary: Participants also kept a pain diary rating their daily pain (0-10 four times 
(Morning, afternoon, evening and night) using the following question: “How would you 
rate your pain at this point in time?” and anchor statements of “no pain” and “worst 
imaginable pain”.  
 
Function: Function was assessed using the Disabilities of the Arm, Shoulder and Hand 
test (DASH) a 30-item questionnaire that is scaled from 0-100. The DASH has a good 
level of validity, reliability and sensitivity to change.25 A change of ≥15 points was 
considered a meaningful improvement26. 
 
Pain Medication Use: Daily medication use was recorded in a diary for each day 
capturing if pain medication was used, and if so what type and dosage (number of pills 
& size (mg) of pills).27 
 
Adverse reactions: If any participant reported an adverse reaction this was recorded.  
 
Perceptual Outcomes 
Hand Laterality Recognition Task: Correctly identifying the laterality (i.e. ‘left’ or 
‘right’) of an image depicting a hand requires the participant to engage in the mental 
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rotation (motor imagery) of their own limbs,28 with optimal performance relying on an 
intact body schema. Previous studies have demonstrated impairment on the task in 
patients with CRPS.29-32 Participants were presented with images of hands on a 
computer screen of varying laterality, view, orientation and rotation; and asked to 
respond as quickly and as accurately as possible.  Presentation of stimuli (images) and 
resulting data (accuracy and response time) were controlled and logged using 
customized software (E-Prime, www.pstnet.com). 
 
Bath CRPS Body Perception Disturbances: The Body Perception Disturbance 
questionnaire assesses a patients’ perception of their affected limb.33 Participants rate 
different aspects of perception such as feelings of ownership and attention. Five of the 
items are on a 0-10 scale, 2 of the items are yes/no answers and the final item is graded 
on a 0-1-2 scale. A total score is scaled from 0-57. Higher scores denote poorer 
perception of the limb. There is no literature identifying what is a meaningful clinical 
improvement on the Body Perception Disturbance questionnaire.  
 
Research outcomes 
Expectation and Blinding: To assess patient expectation at the beginning of the study 
participants were asked to rate the following: A) How helpful do you believe TENS will 
be for your pain?: 0 = not at all helpful 10 = Extremely helpful; B) how helpful do you 
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believe sub threshold TENS will be for your pain?: 0 = not at all helpful 10 = Extremely 
helpful; C) How easy to use do you think TENS will be?: 0 = not at all easy to use 10 = 
extremely easy to use.34 
 
To investigate the appropriateness of the single-blinding procedures, participants were 
asked to make a judgement as to which group they were randomised. The blinding 
assessment method asked the participants two questions. Firstly, “do you believe your 
TENS unit was functioning properly?”. The five possible responses to were: 1) I am 
certain my TENS unit was working properly; 2) I think my TENS unit was probably 
working properly; 3) I have absolutely no idea whether the TENS unit was working 
properly or not; 4) I think my TENS unit was probably not working properly; 5) I am 
certain my TENS unit was not working properly. Secondly, “If above you answered 
properly 3) I have absolutely no idea whether the TENS unit was working properly or 
not – what would you guess 1) functioning properly 2) no functioning properly”. This 
assessment method has been previously used by our group and others in the TENS 
field.35 
 
Recruitment/eligibility: The number of participants recruited over 20 months was used 
to judge the recruitment rate. Additionally the number of participants invited to take 
part but did not meet the eligibility criteria on formal screening were recorded, to assess 
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the eligibility criteria. Participants were invited to provide a reason for not enrolling if 
they wished to do so. 
 
Qualitative Interviews 
All participants were invited to undertake an exit interview at the 3-month point to 
gather patient’s perceptions of the intervention. The brief semi-structured interviews 
(<10 minutes) were audio-recorded and typed verbatim. The interview topic guide is 
shown in table 2. The qualitative methodology used was based on interpretative 
phenomenological analysis (IPA) as described by Smith and Osborn (1998).36 IPA is a 
useful approach for gaining insight into patient experience of an intervention. The 
interviews were undertaken by RK and the primary analysis was undertaken by CR. The 
primary analysis involved the reading and re-reading of transcripts. Notes were made in 
the transcript margins to facilitate the development of emergent themes. The analysis 
was provided to a 2nd member of the team (DM) who read all the transcripts and 
confirmed that the emergent themes were rooted in the data.36 Discussion occurred 
between the CR and DM to develop the final themes that are presented. Participant 
quotes were used to support the theme development.  
 
Insert table 2 
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Data analysis  
Participant characteristics are presented as mean and 1SD. As this was a feasibility 
study, the change in outcomes were investigated using descriptive statistics. The 
qualitative data were analysed thematically. 
 
Results 
Recruitment/eligibility 
Thirteen individuals initially showed interest in participating of whom eight consented 
and were randomised to the TENS (n=6) or placebo TENS group (n=2) (Figure 1). 
There was a 50% drop-out rate with only four participants providing data at the 3 month 
follow-up point. The participant characteristics are shown in table 3. The number of 
usual care physiotherapy sessions received by each participant ranged from 0-14 (table 
3). 
 
Insert figure 1 and table 3 
Clinical outcomes 
Pain: Participants’ outcomes for pain are shown in Figure 2A-C. Only Participant 003 
in the TENS group showed a meaningful improvement post intervention (31% 
improvement post treatment) but not at the three month follow-up (22%). Group mean 
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(SD) pain intensity for the TENS group was 7.2 (2.4), 6.6 (2.8), and 7.8 (1.9), at 
baseline, post-treatment and 3-month follow-up, respectively. Thus, the effect size from 
pre to post treatment was 0.25. For the single placebo group participant (006) with 
post/follow-up data there was a meaningful improvement in pain post-treatment and at 3 
month follow up (74% and 71%, respectively).  
Pain Diary: Only four of the participants used the pain diary. Of these, one participant 
used it for two weeks while the other three used it for all three weeks. The daily pain 
levels and device usage data show no obvious trend between groups (See figure 4A-B).  
Pain medication usage: The pain medication usage diary was sparsely completed and 
provided little or no useful or coherent information. 
Function: Participants’ outcomes for function are shown in Figure 2A-C. Only 
Participant 004 in the TENS group showed a meaningful improvement (24 points at 
three month follow-up). Group mean (SD) DASH scores for the TENS group were 66 
(21), 75 (15), and 67 (30), at baseline, post-treatment and 3-month follow-up, 
respectively. For the single placebo group participant (participant 006), who had 
post/follow-up data, there was no meaningful change in pain.  
Adverse Reactions: None of the participants formally reported an adverse reaction. 
However, during their exit interview, one participant in the placebo group reported 
experiencing a short-term mild increase in hand swelling. 
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Perceptual outcomes 
Hand Laterality Recognition Task28: Participants’ outcomes for hand laterality 
recognition are shown in Figure 3A-D. Inspection of raw data suggests a gradual 
reduction in reaction time in both groups but there was no obvious pattern within the 
accuracy data.   
Bath CRPS Body Perception Disturbance33: Participants’ outcomes for perceived 
body perception are shown in Figure 2A-C. Higher scores denote poorer perception of 
the limb. Group mean (SD) Body Perception Disturbance scores for the TENS group 
were 30 (16), 33 (18), and 33 (21), at baseline, post-treatment and 3-month follow-up, 
respectively. For the single placebo group participant (006) with post/follow-up data 
Body Perception Disturbance scores were 14, 11, and 8, at baseline, post-treatment and 
3-month follow-up, respectively. 
Patient expectations and blinding 
At baseline both the TENS and the placebo groups had similar levels of expectations 
regarding how helpful they believed TENS will be for their pain [5.8 (2.7) vs. 6.5 (0.0)], 
how helpful they believed sub-threshold TENS would be for their pain [5.2 (2.9) vs. 5.0 
(2.1)], and how easy they thought TENS would be to use [6.4 (3.5) vs. 5.8 (5.4)].  
At the 3-month follow-up all three of the participants from the TENS group who 
completed these questions were certain that their TENS unit was working correctly 
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while the one participant from the placebo group thought that the TENS unit was 
working correctly but was not certain.  
Qualitative Interviews 
Four (n=3 TENS and n=1 placebo) participants underwent exit interviews. Two main 
themes were identified: 1) level of perceived benefit and 2) ease of use. 
Theme 1:Level of perceived benefit 
Of the three TENS participants, one clearly stated that they did not find TENS useful: 
“[TENS] didn’t work” [002] 
The other two TENS participants found TENS beneficial. Participant 003 stated that 
when the TENS was being applied it helped to take her mind off her pain and reported 
relief of about 50% when TENS was on but no residual benefit once removed: 
“It took my mind away from the pain while it was on…I would say about 50% 
[reduction in pain]” [003] 
Both of these participants were still regularly using TENS (three or four times a day 
[004]) but were now using it in a continuous mode rather than the pulsed mode that was 
used in the study: 
“I did [get my own TENS machine] yeah and I keep that on the full one [continuous 
mode]” [003] 
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There was no obvious reason identified as to why some participants found TENS 
beneficial and some didn’t. However, the participant reporting no benefit described 
feeling the TENS sensation in their arm/elbow while their main painful area was their 
thumb. In contrast one of the participants who found a benefit specifically reported 
feeling the TENS sensation in the same area as their pain. 
The single participant in the placebo group who undertook an exit interview also felt 
that the TENS had been beneficial though, they qualified that the benefit was small and 
felt that the effect was due to distraction. 
“I think it did decrease pain but only minimally, and I think that was possibly more due 
to distraction rather than actually the TENS” [006] 
This participant noted a short-term adverse event. The participant self-managed this 
adverse event. They did not formally report it as an adverse event within the study itself. 
“A slight increase in swelling in my hand...could be combatted with the compression 
glove” [006] 
Theme 2: Ease of use 
All four participants reported that TENS was easy to use. 
“very easy to use” [002] 
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While, the application of the electrode pads and their associated wires did pose 
challenges patients learned to problem solve the issues independently or with the help of 
a partner. 
“I struggled at first because the wires getting in and out, obviously I can’t pull the wires 
totally out because it’s my right hand…but I have worked it out now I pull the pads 
off…or I just leave them plugged in and my partner takes them out” [004] 
“Other than the fact that I can’t put the pads on my shoulder myself, it’s completely 
usable” [006] 
 
Insert figure 2A-C 
Insert figure 3A-D 
Insert figure 4A-B 
 
Discussion 
We developed a clinical TENS protocol where the electrode pads were applied to the 
upper arm, proximal to the affected site and the TENS sensation projected distally down 
the arm into the affected area. This simple adaption of conventional TENS technique 
(e.g. placing the electrodes over the painful area) was acceptable to participants who 
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reported during interview that the device was easy to use and had no adverse effects 
apart from a short-term mild increase in hand swelling in one participant in the placebo 
group. Participant concordance to the treatment regime was high implying that the 
application technique was acceptable. In addition this feasibility study identified key 
methodological issues, such as pain medication usage recording, which should be taken 
into consideration for a future RCT. 
Recruitment rates were poor. This does not appear to have been the result of 
inappropriate recruitment procedures per se or overly exclusive eligibility criteria. 
When planning this study it was estimated that the pain department hosting the study 
usually had 3 new patients with CRPS per month, with 2 new patients per week 
attending local peripheral clinics. Thus, it was expected that recruitment goals were 
achievable. A number of strategies were put in place to increase recruitment including 
regular updates to staff to raise awareness of the study; however, it is unclear what if 
any effect such strategies had. During the recruitment phase other clinical 
studies/clinical pathways were operating within the hospital, which may have reduced 
the number of individuals directed towards this study. A future large scale RCT should 
be multicentred and consider using existing databases such as the UK CRPS database.37 
 
The pain and TENS usage diary were useful outcome measures though only four of the 
eight participants completed them. The reason for this poor completion is unknown. 
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Those participants who completed diaries did so comprehensively with little missing 
data. The TENS usage data indicated a high level of treatment concordance with usage 
above the recommended 90 minutes in 64 of the 69 reported usage days (93% 
adherence). Assuming zero usage on the days that no information was inputted by the 
four participants this would still indicate 76% concordance (64/84). This high usage 
occurred alongside relatively unchanging pain levels. Pain medication recording was 
inconsistent and ultimately the information provided was difficult to interpret and thus 
unusable. Other methods of monitoring pain medication usage, such as automated 
tracking38 should be explored. In addition, monitoring the number of usual care 
physiotherapy sessions was an important step with respect to monitoring co-
interventions. The number of sessions varied quite considerably between participants 
which may need to be adjusted for in a future fully powered trial.  
 
There were significant challenges with both of the perceptual outcomes: the Hand 
Laterality Recognition Task28 and Body Perception Disturbance questionnaire.33 Due to 
technical difficulties much of the Hand Laterality Recognition Task data was not 
collected. The mean (SD) Body Perception Disturbance score for all participants was 28 
(15), which is higher than previously reported values for CRPS patients (21 (11)).39 The 
Body Perception Disturbance scores showed no obvious pattern with scores remaining 
largely unchanged, and the absence of any existing data regarding minimally important 
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difference makes it difficult to comment upon the importance of the small changes seen.  
The Body Perception Disturbance questionnaire contains a component where the patient 
describes their mental image of their affected limb and this is drawn by the 
assessor/health care professional. This drawing influences the scoring of the 
questionnaire. The clinician reported that the drawing was heavily influenced by their 
artistic ability rather than the patient’s description, questioning the face validity of the 
tool. A complete assessment of the psychometric properties of the Body Perception 
Disturbance has not been undertaken as yet39 but future work may want to consider the 
utility of the drawing component.  
 
The level of expectation in participants regarding both above threshold and sub 
threshold TENS was similar between groups suggesting our approach to make the no 
current placebo TENS, a viable intervention in the eyes of the participants was 
successful. However, regarding blinding at the 3-month follow-up there appeared to be 
an element of doubt about the function of the device in the placebo group that was not 
apparent in the TENS group implying that the blinding of participants may not have 
been completely successful, though it does imply a degree of success. However it is 
difficult to determine from the limited amount of data. 
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Within the qualitative interviews, one participant stated that TENS was of no benefit to 
them, this could have been related to the difficulty in projecting the TENS sensation 
over the painful thumb area for this patient. The other two participants who provided 
interviews in the TENS group both reported finding TENS beneficial. One reported a 
clinically relevant 50% reduction in pain when using TENS and both were still using 
TENS regularly at the 3-month point.  Interestingly they choose to use the continuous 
mode of delivery compared to the burst mode used for repetitive electrical stimulation 
as used in this study. Furthermore, one of the participants emphasised that TENS was 
beneficial during stimulation but effects were short-lived once the TENS device had 
been switched off. It has been argued that TENS pain relief should only be expected 
when in situ and thus outcome measurement to test its effectiveness should occur at this 
point.40 
 
Study implications 
The implications of this study is that this trial does not, as yet, appear feasible at a 
definitive trial level in its current form. Recruitment is a major issue and would need to 
be addressed in further feasibility work before proceeding to a full trial. In addition, data 
collection processes need to be further enhanced, with particular emphasis on the pain 
medication usage diary, the body perception questionnaire33 and the Hand Laterality 
Recognition Task28. One objective of this work was to calculate an effect size to inform 
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a fully powered future trial. For the primary outcome measure of pain, from pre- to 
post-treatment an effect size of 0.25 was shown. Using this effect size, an alpha level of 
0.05, and 80% power, a sample size of 506 participants (253 per group) would be 
required for a fully powered trial. Given the difficulties with recruitment shown in this 
study such a sample size would likely be very difficult to attain. 
 
Study limitations 
This study was limited by a number of factors already discussed above, not least the low 
recruitment rates and the relatively high dropout rates (50%). We did not obtain reasons 
for dropout, this should be explored in future work. The imbalance in the randomisation 
was also an issue. The randomisation had been undertaken to ensure an equal number of 
15 participants would be randomised to each group, however, by chance the random 
sequence initially was loaded towards assigning more to the intervention group rather 
than the placebo group. Blocked randomisation would have prevented this distortion 
and should be used in any future small-scale trials. In addition there was limited 
investigation of fidelity within the study, beyond the monitoring the concordance to the 
recommended usage dose (90 minutes daily) via a diary. Further checks of the quality of 
delivery of the intervention in the participant’s home environment would have been 
useful.  
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Conclusion 
We developed a clinical TENS protocol where the electrode pads were applied to the 
upper arm, proximal to the affected site and the TENS sensation projected distally down 
the arm into the affected area. Participants tolerated TENS well. A number of 
methodological issues were identified, such as low recruitment rates and inadequate 
data collection processes particularly regarding pain medication usage and body 
perception assessment. Thus, further feasibility work across multiple sites, focussing 
upon these methodological issues is warranted prior to undertaking a full scale RCT.  
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Figure Legends 
 
Figure 2A-C: Data are presented for each individual participant. * indicates the 
participant received the placebo intervention. 
Figure 3A-D: Data are presented for each individual participant. * indicates the 
participant received the placebo intervention. 
Figure 4A-B: The top graph (A) shows the average pain daily pain reported by each 
participant that completed a diary. The bottom graph (B) shows the total TENS usage 
time each day for each participant that completed at diary. Missing data was left blank. 
*indicates that participant 6 was in the placebo group while participants 2, 3 and 8 were 
in the intervention group. 
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Table 1: Study objectives 
• To explore participants’ perceptions of the acceptability of TENS as delivered in 
this study. 
• To investigate participants’ concordance with the protocol for home-based 
delivery of TENS and to explore their opinions of factors that may influence 
concordance. 
• To record the occurrence of any adverse effects. 
• To investigate recruitment procedures and rates of recruitment. 
• To investigate the appropriateness of the blinding procedure. 
• To select appropriate outcome measures of limb perception. 
• To investigate the appropriateness of the eligibility criteria. 
• To provide preliminary data on the clinical effectiveness of TENS. 
• To estimate effect sizes for outcome measures to inform future sample size 
calculation. 
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 Table 2: Interview topic guide 
1. What were your general impressions of the treatment? 
2. What were your expectations of treatment and to what degree do you feel these 
expectations were met? 
3. What is your opinion of the usability and acceptability of the 
intervention/placebo? 
4. What is your opinion about using this intervention in the future? 
5. Is there anything else you would like to say about the intervention/study? 
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Table 3: Participant characteristics 
Participant Group Affected side Age Gender TENS position No. of Usual Care  
PT sessions 
001 TENS Left 47 Male Elbow/wrist (median) 4 
002 TENS Right 50 Female Shoulder/elbow 6 
003 TENS Left 34 Female Elbow/wrist (median) 7 
004 TENS Right 32 Female Elbow/wrist (median) 11 
005 TENS Left 34 Male Elbow/wrist (ulnar) 1 
008 TENS Left 37 Female Elbow/wrist (median, 
ulnar, radial) 
5 
006 Placebo Right 29 Female Elbow/wrist (median) 14 
009 Placebo Right 36 Female Hand (median) 20 
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Figure 1: Participant flow diagram 
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Figure 2A: Pain VAS 
 
 
Figure 2B: Disability and Shoulder Assessment (DASH) 
 
Figure 2C: Bath CRPS Body Perception Disturbances (BPD) 
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 Figure Legend 2A-C: Data are presented for each individual participant. * indicates 
the participant received the placebo intervention. 
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Figure 3A-D: Hand Laterality Recognition Task (HLRT) outcomes 
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Figure Legend 3A-D: Data are presented for each individual participant. * indicates 
the participant received the placebo intervention. 
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Figure 3A-B: Pain and TENS usage diary 
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(B) 
 
 
Figure Legend 3A-B: The top graph (A) shows the average pain daily pain reported by 
each participant that completed a diary. The bottom graph (B) shows the total TENS 
usage time each day for each participant that completed at diary. Missing data was left 
blank. *indicates that participant 6 was in the placebo group while participants 2, 3 
and 8 were in the intervention group. 
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